📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

ChimLeish, a new recombinant chimeric protein evaluated as a diagnostic and prognostic marker for visceral leishmaniasis and human immunodeficiency virus coinfection. (2021)

First Author: Galvani NC

Attributed to: VAccine deveLopment for complex Intracellular neglecteD pAThogEns (VALIDATE) funded by GCRF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00436-021-07342-1

PubMed Identifier: 34664113

Publication URI: http://europepmc.org/abstract/MED/34664113

Type: Journal Article/Review

Volume: 120

Parent Publication: Parasitology research

Issue: 12

ISSN: 0932-0113